BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31512980)

  • 1. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
    Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
    Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
    Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry.
    Hruba L; Polishchuk P; Das V; Hajduch M; Dzubak P
    Biomed Pharmacother; 2022 Feb; 146():112549. PubMed ID: 34923338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
    Ashraf GM; DasGupta D; Alam MZ; Baeesa SS; Alghamdi BS; Anwar F; Alqurashi TMA; Sharaf SE; Al Abdulmonem W; Alyousef MA; Alhumaydhi FA; Shamsi A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.
    Anwar S; Shamsi A; Kar RK; Queen A; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2020 Oct; 161():596-604. PubMed ID: 32535203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
    Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Tau Hyperphosphorylation
    Turab Naqvi AA; Hasan GM; Hassan MI
    Curr Top Med Chem; 2020; 20(12):1059-1073. PubMed ID: 31903881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
    Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
    Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
    Annadurai N; Agrawal K; Džubák P; Hajdúch M; Das V
    Cell Mol Life Sci; 2017 Nov; 74(22):4159-4169. PubMed ID: 28634681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
    Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
    Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights.
    Anwar S; Choudhury A; Hussain A; AlAjmi MF; Hassan MI; Islam A
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130090. PubMed ID: 38342269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
    Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
    Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
    J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
    Trinczek B; Brajenovic M; Ebneth A; Drewes G
    J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study.
    Llorach-Pares L; Nonell-Canals A; Avila C; Sanchez-Martinez M
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30332805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases.
    Alam M; Ahmed S; Abid M; Hasan GM; Islam A; Hassan MI
    J Cell Biochem; 2023 Sep; 124(9):1223-1240. PubMed ID: 37661636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.
    Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C
    Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.
    Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI
    J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.